Back to User profile » Prof. Dr. Craig LaForce
Papers published by Prof. Dr. Craig LaForce:
Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies
LaForce C, Derom E, Bothner U, Kloer IM, Trampisch M, Buhl R
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1819-1831
Published Date: 1 June 2018
Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study
LaForce C, Feldman G, Spangenthal S, Eckert JH, Henley M, Patalano F, D’Andrea P
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:1233-1243
Published Date: 8 June 2016
Once-daily indacaterol 75 µg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients’ perceived onset of effect
Siler TM, LaForce CF, Kianifard F, Williams J, Spangenthal S
International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:919-925
Published Date: 1 September 2014